Download Loss of E-Cadherin-Mediated Cell-Cell Adhesion Induces the

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Poster No. 72
Title:
Loss of E-Cadherin-Mediated Cell-Cell Adhesion Induces the Transition from Precancer to Squamous Cell
Carcinoma through Activation of FAK and Src Kinases
Authors:
Addy Alt-Holland, Yonit Szwec-Levine, Daniel Green, Jonathan Garlick
Presented by:
Addy Alt-Holland
Departments:
Division of Cancer Biology and Tissue Engineering, and Departments of Endodontics and of Oral and
Maxillofacial Pathology, Tufts University School of Dental Medicine
Abstract:
The association between loss of cell-cell adhesion and acquisition of enhanced cell migration during early stages
of cancer progression is not well understood. We showed that human skin equivalents (HSEs) harboring
E-cadherin-deficient, early-stage tumor cells mimic premalignancy and are linked to a switch to highly invasive
carcinoma. As FAK (Focal Adhesion Kinase) and Src kinases play key roles in cell adhesion, migration and
invasion, we studied their contribution to the migratory properties of E-cadherin-deficient cells in 2D cultures
and in 3D, bioengineered HSEs. Upon scrape-wounding, E-cadherin-deficient cultures demonstrated single cell
scattering and accelerated wound closure, while E-cadherin-competent cells migrated slowly as polarized cell
sheets. Immunostaining of E-cadherin-competent cells revealed focal localization of FAK at the cell periphery
and of Src at cell-cell borders. In contrast, E-cadherin-deficient cells demonstrated a perinuclear distribution of
FAK and Src, and immunoblotting revealed elevated FAK expression and increased FAK and Src tyrosine
phosphorylation. A pharmacological approach to inhibit cell migration demonstrated that FAK and Src
inhibitors, Tyrphostin-AG1007 and PP2, reduced the phosphorylation of these kinases and reversibly inhibited
E-cadherin-deficient cell migration. Finally, in a novel transepithelial tumor cell migration model, we showed
that loss of cell-cell adhesion was associated with increased FAK expression and allowed E-cadherin-deficient
tumor cells to individually migrate between normal keratinocytes and transverse the epithethlial-stromal
interface. Taken together, E-cadherin suppression is associated with redistribution and upregulation of FAK and
Src kinases directing a highly motile tumor cell phenotype. These kinases may contribute to the transition from
precancer to malignancy during squamous cell carcinoma development. Therapeutic approaches designed to
target these kinases and block transepithelial tumor cell migration may pave the way towards elimination of
such lesions and cancer prevention.
79